secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001437749-24-018902
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen stockholders approve major increase in authorized equity shares
------------------------------------------------------------------------

- Approved amendment to 2019 Omnibus Equity Incentive Plan: authorized shares increase from 1M to 5M; 82.0% votes cast in favor.
- Approved amendment to 2019 Employee Stock Purchase Plan: authorized shares increase from 33,334 to 1M; 82.3% votes cast in favor.
- Both proposals passed at special meeting held May 29, 2024, with over 82% of votes cast supporting each.
- Total potential dilution from the two plan amendments increases available shares by 4.97M (net of prior reserves).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924018902/0001437749-24-018902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924018902/vtgn20240529_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer